Work

A phase I combination study of olaparib (AZD2281; KU-0059436) and cisplatin (C) plus gemcitabine (G) in adults with solid tumors.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.3027

Authors: G. Giaccone, A. Rajan, R. J. Kelly, M. Gutierrez, S. Kummar, M. Yancey, J. J. Ji, Y. Zhang, R. E. Parchment, J. H. Doroshow

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2336058493

Cites:

Cited by: 37

Related to: 10